The complex task of measuring intestinal permeability in basic and clinical science

Neurogastroenterology and Motility

Volumn 28, Issue 7, 2016, Pages 957-965

  Galipeau, H J ^a   Verdu, E F ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

intestinal permeability; paracellular permeability; transcellular permeability

Indexed keywords

BIOLOGICAL MARKER;

BASIC RESEARCH; EX VIVO STUDY; HUMAN; IN VITRO STUDY; INTESTINE LOOP; INTESTINE MUCOSA PERMEABILITY; PRIORITY JOURNAL; REVIEW;

EID: 84977074003     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12871     Document Type: Review

References (49)

1. Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 2013; 11: 1075–83.
2. Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, Tilg H, Watson A et al. Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol 2014; 14: 189.
3. Zakostelska Z, Kverka M, Klimesova K, Rossmann P, Mrazek J, Kopecny J, Hornova M, Srutkova D et al. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS ONE 2011; 6: e27961.
4. Laval L, Martin R, Natividad J, Chain F, Miquel S, De Maredsous CD, Capronnier S, Sokol H et al. Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice. Gut Microbes 2015; 6: 1–9.
5. Leffler DA, Kelly CP, Green PH, Fedorak RN, DiMarino A, Perrow W, Rasmussen H, Wang C et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology 2015; 148: 1311–9 e1316.
6. McCarville JL, Caminero A, Verdu EF. Pharmacological approaches in celiac disease. Curr Opin Pharmacol 2015; 25: 7–12.
7. Raftery T, Martineau AR, Greiller CL, Ghosh S, McNamara D, Bennett K, Meddings J, O'Sullivan M. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: results from a randomised double-blind placebo-controlled study. United European Gastroenterol J 2015; 3: 294–302.
8. Kelly C, Green P, Murray J, Dimarino A, Colatrella A, Leffler D, Alexander T, Arsenescu R et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther 2013; 37: 252–62.
9. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 2014; 14: 141–53.
10. De Santis S, Cavalcanti E, Mastronardi M, Jirillo E, Chieppa M. Nutritional keys for intestinal barrier modulation. Front Immunol 2015; 6: 612.
11. Michielan A, D'Incà R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm 2015; 2015: 628157.
12. Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010; 3: 247–59.
13. Neutra MR, Mantis NJ, Kraehenbuhl J-P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001; 2: 1004–9.
14. + dendritic cells in the small intestine. Nature 2012; 483: 345–9.
15. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013; 70: 631–59.
16. Camilleri M, Madsen K, Spiller R, Van Meerveld B, Verne G. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 2012; 24: 503–12.
17. Liverani E, Scaioli E, Digby RJ, Bellanova M, Belluzzi A. How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol 2016; 22: 1017–33.
18. 13C mannitol as a novel biomarker for measurement of intestinal permeability. Neurogastroenterol Motil 2016; 28: 1114–9.
19. Quigley E. Leaky gut - concept or clinical entity? Curr Opin Gastroenterol 2016; 32: 74–9.
20. Sequeira IR, Lentle RG, Kruger MC, Hurst RD. Differential trafficking of saccharidic probes following aspirin in clinical tests of intestinal permeability in young healthy women. Clin Exp Pharmacol Physiol 2014; 41: 107–17.
21. Sequeira IR, Lentle RG, Kruger MC, Hurst RD. Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability. PLoS ONE 2014; 9: e99256.
22. Wang L, Llorente C, Hartmann P, Yang A-M, Chen P, Schnabl B. Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods 2015; 421: 44–53.
23. Natividad JMM, Petit V, Huang X, de Palma G, Jury J, Sanz Y, Philpott D, Garcia Rodenas CL et al. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1−/−; Nod2−/− mice. Inflamm Bowel Dis 2012; 18: 1434–46.
24. Volynets V, Reichold A, Bárdos G, Rings A, Bleich A, Bischoff SC. Assessment of the intestinal barrier with five different permeability tests in healthy C57BL/6J and BALB/cJ mice. Dig Dis Sci 2016; 61: 737–46.
25. Ménard S, Lebreton C, Schumann M, Matysiak-Budnik T, Dugave C, Bouhnik Y, Malamut G, Cellier C et al. Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am J Pathol 2012; 180: 608–15.
26. Galipeau HJ, Rulli NE, Jury J, Huang X, Araya R, Murray JA, David CS, Chirdo FG et al. Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J Immunol 2011; 187: 4338–46.
27. Pinier M, Fuhrmann G, Galipeau H, Rivard N, Murray JA, David CS, Drasarova H, Tuckova L et al. The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. Gastroenterology 2012; 142: 316–25 e1-12.
28. Clarke LL. A guide to Ussing chamber studies of mouse intestine. Am J Physiol Gastrointest Liv Physiol 2009; 296: G1151–66.
29. Scherer D, Mooren FC, Kinne R, Kreuter J. In vitro permeability of PBCA nanoparticles through porcine small intestine. J Drug Target 1993; 1: 21–7.
30. Balimane PV, Chong S, Morrison RA. Current methodologies used for evaluation of intestinal permeability and absorption. J Pharmacol Toxicol Methods 2000; 44: 301–12.
31. Velin ÅK, Ericson A-C, Braaf Y, Wallon C, Söderholm JD. Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats. Gut 2004; 53: 494–500.
32. Verschoor CP, Naidoo A, Wallace JG, Johnstone J, Loeb M, Bramson JL, Bowdish DM. Circulating muramyl dipeptide is negatively associated with interleukin-10 in the frail elderly. Inflammation 2015; 38: 272–7.
33. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119: 1496–505.
34. Relja B, Szermutzky M, Henrich D, Maier M, De Haan JJ, Lubbers T, Buurman WA, Marzi I. Intestinal-FABP and liver-FABP: novel markers for severe abdominal injury. Acad Emerg Med 2010; 17: 729–35.
35. Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, Van der Zee DC, Brouwers HA et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010; 251: 1174–80.
36. Reisinger KW, Derikx JP, Thuijls G, van der Zee DC, Brouwers HA, van Bijnen AA, Wolfs TG, van Heurn LE et al. Noninvasive measurement of intestinal epithelial damage at time of refeeding can predict clinical outcome after necrotizing enterocolitis. Pediatr Res 2012; 73: 209–13.
37. Adriaanse M, Tack G, Passos VL, Damoiseaux J, Schreurs M, Wijck K, Riedl R, Masclee A et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther 2013; 37: 482–90.
38. Vreugdenhil AC, Wolters VM, Adriaanse MP, Van den Neucker AM, van Bijnen AA, Houwen R, Buurman WA. Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Scand J Gastroenterol 2011; 46: 1435–41.
39. Grootjans J, Thuijls G, Verdam F, Derikx J, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg 2010; 2: 61–9.
40. Sun X-Q, Fu X-B, Zhang R, Lu Y, Deng Q, Jiang X, Sheng Z. Relationship between plasma D (-)-lactate and intestinal damage after severe injuries in rats. World J Gastroenterol 2001; 7: 555–8.
41. van Vliet MJ, Tissing WJ, Rings EH, Koetse HA, Stellaard F, Kamps WA, de Bont ES. Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients. Pediatr Blood Cancer 2009; 53: 1188–94.
42. Lutgens LC, Blijlevens N, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration. Cancer 2005; 103: 191–9.
43. Bennett-Guerrero E, Barclay GR, Weng PL, Bodian CA, Feierman DE, Vela-Cantos F, Mythen MG. Endotoxin-neutralizing capacity of serum from cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15: 451–4.
44. Weaver L, Coombs R. Does ‘sugar'permeability reflect macromolecular absorption? A comparison of the gastro-intestinal uptake of lactulose and beta-lactoglobulin in the neonatal guinea pig. Int Arch Allergy Appl Immunol 1988; 85: 133–5.
45. Fritscher-Ravens A, Schuppan D, Ellrichmann M, Schoch S, Röcken C, Brasch J, Bethge J, Böttner M et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014; 147: 1012–20 e1014.
46. Lim LG, Neumann J, Hansen T, Goetz M, Hoffman A, Neurath MF, Galle PR, Chan YH et al. Confocal endomicroscopy identifies loss of local barrier function in the duodenum of patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2014; 20: 892–900.
47. Günther U, Daum S, Heller F, Schumann M, Loddenkemper C, Grünbaum M, Zeitz M, Bojarski C. Diagnostic value of confocal endomicroscopy in celiac disease. Endoscopy 2010; 42: 197–202.
48. Buda A, Hatem G, Neumann H, D'Incà R, Mescoli C, Piselli P, Jackson J, Bruno M et al. Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: a pilot study. J Crohns Colitis 2014; 8: 304–11.
49. Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427–34.